Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum
Clinical trial NCT06040346 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06040346
- Sponsor
- Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2025-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.